Paid Clinical Trials in Huntington Beach, CA
As of August 2026, 76 paid clinical trials are recruiting in Huntington Beach, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Huntington Beach offers studies at sites including City of Hope Seacliff for conditions such as Atopic Dermatitis, Atrial Fibrillation (AF), Geographic Atrophy Secondary to Age-related Macular Degeneration, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Huntington Beach
Trials by drug in Huntington Beach
Filter results
Newly added in Huntington Beach
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
73 clinical trials
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Top Research Study Locations in Huntington Beach
Researchers run research studies in Huntington Beach, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Seacliff | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | 10 |
| Marvel Clinical Research | Atopic Dermatitis, Diabetic Peripheral Neuropathic Pain, Eczema, Atopic | 7 |
| Retina Associates of Southern California | Diabetic Macular Edema, Dry Age-related Macular Degeneration, Geographic Atrophy | 6 |
| Care Access - Huntington Beach | Alzheimer Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Dementia | 3 |
| Keck Medicine of USC Huntington Beach | Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Liver, Metastatic Renal Cell Carcinoma | 3 |
| Newport Huntington Medical Group | Arthritis, Psoriatic, Overweight or Obesity, Psoriatic Arthritis | 3 |
| City of Hope | EGFR/HER2 Exon 20 Insertion Mutation, NSCLC, Non-Small Cell Lung Cancer | 2 |
| National Institute of California Heart and Vein Specialists | Atrial Fibrillation (AF) | 2 |
| National Institute of Clinical Research | Heart, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | 2 |
| Newport Huntington Medical Group | Rheumatoid Arthritis, Psoriatic Arthritis | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| AME Clinical Research | Diabetic Kidney Disease (DKD) | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Allergy and Asthma Specialists Group | Chronic Spontaneous Urticaria (CSU) | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Azul Vision, INC | Persistent Corneal Epithelial Defect | 1 |
| Beach Physicians Medical Group Inc. | Osteoarthritis (OA) of the Knee | 1 |
| California Aesthetic Center | Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV | 1 |
| California Heart Specialist | Heart Failure, Obesity | 1 |
| Care Access Research - Huntington Beach | Systemic Lupus Erythematosus (SLE) | 1 |
| City Of Hope - Seacliff | Non Small Cell Lung Cancer | 1 |
| City of Hope at Seacliff | Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Diabetes Lipid Management Center | Cardiovascular Disease and Lipoprotein(a) | 1 |
Active & Upcoming Studies in Huntington Beach (2026)
Recruiting trials in Huntington Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 · Phase 2 · City of Hope Medical Center
- Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial · Phase 2 · City of Hope Medical Center
Eye & vision (12 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
Diabetes & metabolic (4 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes · Phase 3 · Sanofi
Neurology & pain (2 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
HIV / STI (1 active study)
Common conditions studied in Huntington Beach
- Atopic Dermatitis (3 active studies)
- Atrial Fibrillation (AF) (3 active studies)
- Geographic Atrophy Secondary to Age-related Macular Degeneration (3 active studies)
- Heart Failure (3 active studies)
- Asthma (2 active studies)
- Eczema, Atopic (2 active studies)
Leading research sponsors in Huntington Beach
- City of Hope Medical Center
- AbbVie
- Eli Lilly and Company
- Regeneron Pharmaceuticals
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntington Beach?
There are approximately 76 recruiting clinical trials in Huntington Beach, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntington Beach pay participants?
Most recruiting trials in Huntington Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntington Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntington Beach?
The most common conditions under active study in Huntington Beach include Atopic Dermatitis (3), Atrial Fibrillation (AF) (3), Geographic Atrophy Secondary to Age-related Macular Degeneration (3), Heart Failure (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntington Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntington Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntington Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntington Beach?
Recruiting research sites in Huntington Beach include City of Hope Seacliff, Marvel Clinical Research, Retina Associates of Southern California, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntington Beach right now?
The largest active categories in Huntington Beach are Cancer & tumors (14), Eye & vision (12), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.